AU2020900536A0 - Treatment of proliferative diseases of the cns - Google Patents

Treatment of proliferative diseases of the cns

Info

Publication number
AU2020900536A0
AU2020900536A0 AU2020900536A AU2020900536A AU2020900536A0 AU 2020900536 A0 AU2020900536 A0 AU 2020900536A0 AU 2020900536 A AU2020900536 A AU 2020900536A AU 2020900536 A AU2020900536 A AU 2020900536A AU 2020900536 A0 AU2020900536 A0 AU 2020900536A0
Authority
AU
Australia
Prior art keywords
cns
treatment
proliferative diseases
proliferative
diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
AU2020900536A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aucentra Therapeutics Pty Ltd
Original Assignee
Aucentra Therapeutics Pty Ltd
Filing date
Publication date
Application filed by Aucentra Therapeutics Pty Ltd filed Critical Aucentra Therapeutics Pty Ltd
Publication of AU2020900536A0 publication Critical patent/AU2020900536A0/en
Withdrawn legal-status Critical Current

Links

AU2020900536A 2020-02-25 Treatment of proliferative diseases of the cns Withdrawn AU2020900536A0 (en)

Publications (1)

Publication Number Publication Date
AU2020900536A0 true AU2020900536A0 (en) 2020-03-12

Family

ID=

Similar Documents

Publication Publication Date Title
EP3781564A4 (en) Compounds for the treatment of cancer
EP3986392A4 (en) Compounds for treatment of pd-l1 diseases
EP3621973A4 (en) Compounds for the prevention and treatment of diseases and the use thereof
EP4146201A4 (en) Treatment of proliferative diseases of the cns
EP3761970A4 (en) Compositions and methods for the treatment of neurological diseases
EP4045036A4 (en) Heteroaryl-biphenyl amides for the treatment of pd-l1 diseases
EP3600286A4 (en) Compounds and methods for the treatment of parasitic diseases
EP3969597A4 (en) Compositions and methods for the treatment of atpase-mediated diseases
EP3955937A4 (en) Compounds and methods for the treatment of ocular disorders
EP4045037A4 (en) Heteroaryl-biphenyl amines for the treatment of pd-l1 diseases
EP3927706A4 (en) Imidazopyridinyl compounds and use thereof for treatment of proliferative disorders
EP3955926A4 (en) Compounds and methods for the treatment of ocular disorders
EP3952881A4 (en) Compositions and methods for the treatment of contact lens discomfort
SG11202108636SA (en) Indazolyl-isoxazole derivatives for the treatment of diseases such as cancer
EP3877382A4 (en) Novel compounds for the treatment of respiratory diseases
EP4010075A4 (en) Methods for the treatment of apoc3-related diseases and disorders
EP4017490A4 (en) Compounds and methods for treating oxalate-related diseases
EP3938364A4 (en) Compounds for and methods of treating diseases
EP3955914A4 (en) Novel compounds and methods of use treating fructose-related disorders or diseases
EP3829560A4 (en) Compounds for the treatment of neurological or mitochondrial diseases
AU2022298746A1 (en) Beta-lactam derivatives for the treatment of diseases
AU2020901435A0 (en) Treatment of proliferative diseases of the cns
AU2020900536A0 (en) Treatment of proliferative diseases of the cns
EP4027984A4 (en) Combination therapy for the treatment of migraines
EP3866795A4 (en) Treatment of neurological diseases